Literature DB >> 10090141

Progression of a Nelson's adenoma to pituitary carcinoma; a case report and review of the literature.

S A Kemink1, P Wesseling, G F Pieters, A A Verhofstad, A R Hermus, A G Smals.   

Abstract

A 25-year-old woman developed Nelson's syndrome, 3 years after successful bilateral adrenalectomy for Cushing's disease. Despite pituitary surgery and radiotherapy the tumour showed invasive growth, leading to visual disturbance, paresis of the oculomotor nerve and, 34 years after adrenalectomy, to death by widespread purulent leptomeningitis. Autopsy revealed a large adenohypophyseal carcinoma with a metastasis attached to the dura, both tumours showing immunocytochemical staining for ACTH and TSH. We review the literature on metastatic adenohypophyseal carcinoma in Cushing's disease and Nelson's syndrome and discuss the role of proliferation markers as indicators of malignant progression.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10090141     DOI： 10.1007/BF03345482

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


  37 in total

1.  p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions.

Authors:  K Thapar; B W Scheithauer; K Kovacs; P J Pernicone; E R Laws
Journal:  Neurosurgery       Date:  1996-04       Impact factor: 4.654

2.  Nelson's syndrome: frequency, prognosis, and effect of prior pituitary irradiation.

Authors:  T J Moore; R G Dluhy; G H Williams; J P Cain
Journal:  Ann Intern Med       Date:  1976-12       Impact factor: 25.391

3.  Pituitary pro-opiomelanocortin-cell carcinoma occurring in conjunction with a glioblastoma in a patient with Cushing's disease and subsequent Nelson's syndrome.

Authors:  J L Gabrilove; P J Anderson; N S Halmi
Journal:  Clin Endocrinol (Oxf)       Date:  1986-08       Impact factor: 3.478

4.  Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma.

Authors:  M Brada; D Ford; S Ashley; J M Bliss; S Crowley; M Mason; B Rajan; D Traish
Journal:  BMJ       Date:  1992-05-23

5.  Flow cytometry analysis of pituitary adenomas.

Authors:  O Fornas; M E Mato; M Viader; B Oliver; P Tresserres; F Bartumeus; D Tugues; J Pétriz; X Matías-Guiu; S M Webb
Journal:  Horm Res       Date:  1996

6.  Prolactin secreting pituitary carcinoma.

Authors:  T Petterson; I A MacFarlane; J M MacKenzie; M D Shaw
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-12       Impact factor: 10.154

Review 7.  [Primary carcinoma of the pituitary gland with Cushing's syndrome and metastases. Apropos of a case with review of the literature].

Authors:  H Lévesque; P Fréger; A Gancel; J Tayot; H Courtois
Journal:  Rev Med Interne       Date:  1991 May-Jun       Impact factor: 0.728

8.  Proliferation Markers and EGF in ACTH-Secreting Adenomas and Carcinomas of the Pituitary.

Authors:  Dorothee Lubke; Wolfgang Saeger; Dieter K. Ludecke
Journal:  Endocr Pathol       Date:  1995       Impact factor: 3.943

9.  G-protein mutations in human pituitary adrenocorticotrophic hormone-secreting adenomas.

Authors:  E A Williamson; P G Ince; D Harrison; P Kendall-Taylor; P E Harris
Journal:  Eur J Clin Invest       Date:  1995-02       Impact factor: 4.686

10.  A pituitary parasellar tumor with extracranial metastases and high, partially suppressible levels of adrenocorticotropin and related peptides.

Authors:  F E Kaiser; D N Orth; K Mukai; J H Oppenheimer
Journal:  J Clin Endocrinol Metab       Date:  1983-09       Impact factor: 5.958
View more
  12 in total

Review 1.  Corticotrophic pituitary carcinoma with cervical metastases: case series and literature review.

Authors:  Frederick Yoo; Edward C Kuan; Anthony P Heaney; Marvin Bergsneider; Marilene B Wang
Journal:  Pituitary       Date:  2018-06       Impact factor: 4.107

Review 2.  Pituitary carcinoma: report of an exceptional case and review of the literature.

Authors:  C Pichard; S Gerber; M Laloi; M Kujas; S Clemenceau; D Ponvert; E Bruckert; G Turpin
Journal:  J Endocrinol Invest       Date:  2002-01       Impact factor: 4.256

3.  Non-functioning pituitary carcinoma.

Authors:  Petra Nadja Elsässer Imboden; François-Xavier Borruat; Nicolas De Tribolet; Kathleen Meagher-Villemure; Alesia Pica; Fulgencio Gomez
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

Review 4.  Corticotroph pituitary carcinoma: case report and literature review.

Authors:  D J Holthouse; P D Robbins; R Kahler; N Knuckey; P Pullan
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

5.  An Institutional Experience of Tumor Progression to Pituitary Carcinoma in a 15-Year Cohort of 1055 Consecutive Pituitary Neuroendocrine Tumors.

Authors:  Omalkhaire M Alshaikh; Sylvia L Asa; Ozgur Mete; Shereen Ezzat
Journal:  Endocr Pathol       Date:  2019-06       Impact factor: 3.943

6.  An unusual presentation of Nelson's syndrome with apoplexy and subarachnoid hemorrhage.

Authors:  Nurperi Gazioğlu; Pinar Kadioğlu; Eylem Ocal; Haldun Erman; Ziya Akar; Büge Oz
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

Review 7.  Malignant pituitary corticotroph adenomas: report of two cases and a comprehensive review of the literature.

Authors:  Agatha A van der Klaauw; Tina Kienitz; Christian J Strasburger; Johannes W A Smit; Johannes A Romijn
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

8.  Triple jeopardy in the pituitary.

Authors:  Kian-Peng Goh; Hwei-Yee Lee; Raja C Rajasoorya
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

9.  ACTH-producing carcinoma of the pituitary with refractory Cushing's Disease and hepatic metastases: a case report and review of the literature.

Authors:  Scott N Pinchot; Rebecca Sippel; Herbert Chen
Journal:  World J Surg Oncol       Date:  2009-04-08       Impact factor: 2.754

Review 10.  Recent advances in understanding corticotroph pituitary tumor initiation and progression.

Authors:  Ulrich Renner; Denis Ciato; Günter K Stalla
Journal:  F1000Res       Date:  2018-08-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.